The Gradinaru Lab develops custom recombinant adeno-associated virus vectors (AAVs) for more efficient and targeted gene transfer in vivo and uses advanced technologies such as optogenetics, tissue-clearing, and imaging to understand physiology and behavior and develop therapies for neurological diseases
Research Highlights
2021: New Technology is One Step Closer to Targeted Gene Therapy
2020: High-Throughput Method Speeds Discovery of Improved Vectors For Gene Delivery To Diverse Brain Cell Types
Research
Where are we now, and what’s ahead?
Publications
A full list of our published work
Talks by Dr. Gradinaru
Dr. Gradinaru’s talks at various events
News
Check here for the latest updates
Awards
People
Life @GLab/Caltech
What’s life like in the G-Lab?
Resources
Check here for lab resources
